Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method

Authors

  • Giovanna Ferraioli Infectious Diseases Department, Fondazione IRCCS Policlinico S. Matteo, Medical School University of Pavia, Pavia, Italy
  • Laura Maiocchi Infectious Diseases Department, Fondazione IRCCS Policlinico S. Matteo, Medical School University of Pavia, Pavia, Italy
  • Raffaella Lissandrin Infectious Diseases Department, Fondazione IRCCS Policlinico S. Matteo, Medical School University of Pavia, Pavia, Italy
  • Carmine Tinelli Clinical Epidemiology and Biometric Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
  • Annalisa De Silvestri Clinical Epidemiology and Biometric Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
  • Carlo Filice Infectious Diseases Department, Fondazione IRCCS Policlinico S. Matteo, Medical School University of Pavia, Pavia, Italy

DOI:

https://doi.org/10.15403/jgld.2014.1121.262.fer

Keywords:

transient elastography, shear wave elastography, liver cirrhosis, chronic hepatitis C, liver stiffness

Abstract

Aims: To prospectively assess the cutoff values of a point shear wave measurement (SWM) method for ruling-in and ruling-out significant fibrosis and cirrhosis using transient elastography (TE) as the reference standard.
Method: Consecutive patients with chronic hepatitis C were enrolled. Liver stiffness was assessed with the SWM method implemented on the HI VISION Ascendus ultrasound system (Hitachi Ltd, Japan) and with the TE method of the FibroScan® device (Echosens, France). For staging significant fibrosis (F≥2) and cirrhosis (F=4) we used the TE cutoffs of 7.0 and 12.0 kiloPascal (kPa), respectively. The diagnostic performance of SWM was assessed by calculating the area under the receiver operating characteristic (AUROC) curve. Cutoffs with specificity or sensitivity > 90% were chosen to rule-in or rule-out F≥2 and F=4.
Results: 445 individuals [235 males, 210 females; mean age, 61.1 (13.3) years] were studied: 190 (42.7%) individuals had F0-F1 fibrosis stage, 82 (18.4%) F2, 46 (10.3%) F3, and 127 (28.6%) F4 fibrosis stage. For ruling-in F≥2 the SWM cutoff was 6.78 kPa [sensitivity, 76.9%(70.6-82.4); specificity, 90.3% (85.0-94.3)] and for ruling-out it was 5.55 kPa [sensitivity, 90.6% (85.8-94.1); specificity, 72.2% (64.9-78.6)]. For ruling-in F=4 the SWM cutoff was 9.15 kPa [sensitivity, 83.3% (74.4-90.2); specificity, 90.1% (86.0-93.2)] and for ruling-out it was 8.41 kPa [sensitivity, 90.6% (82.9-95.6); specificity, 82.2% (77.3-86.4)]. AUROCs were 0.92 (0.89-0.94) for F≥2 and 0.94 (0.91-0.96) for F=4.
Conclusions. In clinical practice, the use of a dual cutoff of SWM may increase the confidence in staging liver fibrosis with a non-invasive shear wave elastography technique.
Abbreviations: ARFI: acoustic radiation force impulse; AUROC: area under the ROC curve; CCC: concordance correlation coefficient; IQR/M: interquartile range/median; LSM: liver stiffness measurement; ROC: receiver operating characteristic; pSWE: point shear wave elastography; SWM: shear wave measurement; TE: transient elastography; US: ultrasound.

Downloads

Published

2017-06-01

How to Cite

1.
Ferraioli G, Maiocchi L, Lissandrin R, Tinelli C, De Silvestri A, Filice C. Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method. JGLD [Internet]. 2017 Jun. 1 [cited 2026 Jul. 19];26(2):139-43. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/958

Issue

Section

Original Article